ArticleClinical science (London, England : 1979)2024

REV-ERBα agonist SR10067 attenuates Th2 cytokine-mediated barrier dysfunction in human bronchial epithelial cells.

Santhosh Kumar Duraisamy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.